Clinical trial
Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine…
NCT00334607 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00334607 |
|---|---|
| Title | Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA |
| Official title | Assess the Immunogenicity of 3 Doses of Pediarix®, Prevnar® & ActHIB® Given to Healthy Infants When Administered With GSK Biologicals' 2 Dose Oral Live Attenuated Human Rotavirus Vaccine Given During the Same Vaccination Visit or Separately |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infections, Rotavirus |
| Intervention type | Biological |
| Interventions | 2-dose oral live attenuated G1P[8] human rotavirus vaccine |
| Enrollment | 484 |
| Start date | Jun 1, 2006 |
| Primary completion | Feb 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Jun 8, 2006 |
| Last update posted | Nov 4, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: